What is PSMA, and why does it matter? An over expression of PSMA has been linked to #prostatecancer and worse outcomes for patients. Staying proactive is key to managing disease. No matter how small your concern is each question matters. #Movember go.novartis.social/49cnHNk

This November, we are honoring and celebrating the United States Armed Forces and shining a light on men’s health issues—including prostate cancer. Learn more about how Novartis & Veterans Prostate Cancer Awareness supports this disproportionately impacted community: go.novartis.social/3ssa7oy

We are proud to support US military #veterans. This #VeteransDay2023, hear from our team member Ryan who joined our sales force after learning about our partnerships with veteran-owned businesses: go.novartis.social/46d9mNU

The Novartis team members at our new Indianapolis facility are fueled by the drive to innovate and the opportunity to make innovative medicines a reality for patients today and tomorrow. #radioligandtherapy

#Radioligandtherapy (RLT) manufacturing is an intricate process requiring precision and urgency. Each day, we strive for operational excellence and race against time to help deliver RLTs to patients.

#Movember: Your PSMA levels can determine the health of your prostate and if you need to seek additional care. Stay proactive – consult your doctor and schedule regular check-ups to stay on top of your prostate health. go.novartis.social/3srhLiV

Today, Indiana state officials, and professional and patient groups joined us for an opening ceremony event to celebrate our new #radioligandtherapy manufacturing facility in Indianapolis. RLT is changing the way cancer is treated, and Novartis is proud to lead the way.

We look forward to connecting at #ASCO24 and #EHA24 on new developments that may help adults with newly diagnosed #CML. Let’s #ReimagineMedicine together.

Discover “More Than Just Words” – the result of a collaboration with a diverse team of experts to champion health equity in breast cancer care. Together, we can address disparities in care and #ReimagineMedicine for all. Learn more at #ASCO2024. Novartis Cancer

At #ASCO2024, we’re highlighting the latest NATALEE analysis of patients with N0 #EBC at high risk of recurrence, who have limited options in reducing their chance of cancer coming back. #NovartisNews #BreastCancer novartis.social/6012Yc5TQ

What does the promise of next-generation cancer treatment look like? With #Radioligandtherapy (RLT), it could be a redefined standard of care for people living with advanced cancers. Learn more at #ASCO24: go.novartis.social/3X1oXz8

Through our “More Than Just Words” initiative, we have created an immersive virtual reality experience. Its purpose? To forge stronger bonds between healthcare providers and their Black patients. Explore this transformative tool at #ASCO2024.

When communities collaborate, that’s when patients win. Bringing together experts at the Chronic Myeloid Leukemia (#CML) Patient Advocate and Medical Expert Leadership Summit at #ASCO2024 sparked a journey to #reimaginemedicine together for patients living with this #bloodcancer.

#ASCO24 reinforced the collective effort to transform cancer care. As we #Reimaginemedicine together with advocacy groups and healthcare professionals, we are exploring ways that collaboration can bring innovation to #Radioligandtherapy. Learn more: go.novartis.social/3R2aJdO

We are honored to be a nominee for the @GalienFDN 2024 #PrixGalien USA Award for Best Pharmaceutical Product. This recognition reflects our commitment to the present—and the future—of #radioligandtherapy as we continue #reimaginingmedicine for people living with cancer.

With these planned expansions and our existing network of manufacturing facilities, we can focus on continuing to make this innovation a reality for the people who need it most.